Psychoactive Substances Taken with Mephedrone and HCV Infection
Background: In recent years, the observed frequency of hospitalization of patients taking mephedrone with other psychoactive substances has increased. There are no data in the literature on the effect of mephedrone use on liver function in patients, including the frequency of HCV infection. We have...
Main Authors: | Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/15/3218 |
Similar Items
-
The psychoactive drug of abuse mephedrone differentially disrupts blood-brain barrier properties
by: Tetyana P. Buzhdygan, et al.
Published: (2021-03-01) -
Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats
by: Klára Šíchová, et al.
Published: (2018-01-01) -
Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances
by: Aniela Golub, et al.
Published: (2023-05-01) -
Roar of meow-meow (mephedrone) in India
by: Pooja Yudhishthir Palkar, et al.
Published: (2015-01-01) -
The effect of mephedrone on human neuroblastoma and astrocytoma cells
by: Ibrahim M. Alanazi, et al.
Published: (2024-04-01)